Gut-Brain Research Moves From Skepticism Into Trials
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The gut microbiome — roughly 100 trillion microbial cells from as many as 5,000 species — communicates with the brain via the vagus nerve and the enteric nervous system's ~500 million neurons, which is more than double the number in the spinal cord.
- Phil Burnet of the University of Oxford recalled that gut-brain researchers were laughed at 15 years ago, but the field has since accelerated rapidly as probiotics, prebiotics, and postbiotics moved into formal clinical testing.
- King's College London and ADM published a 2023 study in JAMA Psychiatry in which a probiotic produced measurable effects on cognitive and emotional processing in people with major depression.
- ADM researchers found that both live and heat-treated bacterial strains produced similar results in adults with IBS, demonstrating that dead microbes can still trigger biological responses in the gut and nervous system.
- Postbiotics triggered physiological changes within an hour of administration, but the effects wore off once participants stopped taking them — suggesting a direct, transient mechanism rather than a permanent reshaping of gut microbiota.
- ADM ran a 72-person trial testing whether postbiotics can reduce symptoms of allergic rhinitis, illustrating how the field is expanding beyond gut and brain conditions.
- Scientists say larger, longer-duration studies are now needed to confirm findings across depression, anxiety, bipolar disorder, OCD, ADHD, stress, and early Alzheimer's research, where work is just beginning.
Why it matters: ADM and rivals developing pre-, pro-, and postbiotic formulations stand to open a new commercial mental-health category if larger trials confirm the early signals — but researchers stress evidence still rests on mostly small studies, so clinical practice could shift quickly as longer data arrives.
